Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

BioPorto - Opdatering på Q2 2024

By Claus ThestrupCEO, Sweden
BioPorto

Du kan allerede nu tilmelde dig eventet og sende dine spørgsmål ind. Du behøver ikke at deltage live for at sende spørgsmål til præsentationen.

Mød og stil spørgsmål til CEO Peter Mørch Eriksen fra Bioporto d. 15. august 2024 kl. 10.30 når han giver investorer en opdatering på Q2 2024 for BioPorto.

Fokus vil være på udviklingen af NGAL-salget i US og resten af verdenen, samt en opdatering på eksekveringen af første del af den nye strategiplan.

Disclaimer: HC Andersen Capital modtager betaling fra Bioporto for en Digital IR/Corporate Visibility og IR advisory abonnementsaftale./Claus Thestrup 11-07-2024 kl. 14.57.

Recent videos

UPM and Sappi are planning a joint venture in graphic papers
04.12.2025, 13.00 UPM-Kymmene
GreenMobility: How far away are driverless cars in Denmark
04.12.2025, 11.32 GreenMobility
Systemair, Audiocast, Q2'25/26
04.12.2025, 09.00 Systemair
HCA Morgenbørs 03/12 - Overvejende positive futures og fokus på ISS
03.12.2025, 09.23 Novo Nordisk
Hafnia – Presentation of the quarterly report for Q3 2025
02.12.2025, 11.00 Hafnia
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.